Tute Genomics Selected by Affiliated Genetics for Clinical Genome Interpretation Tute launches automated clinical reporting for CLIA-certified genetics labs at ACMG, enabling Genome-guided Personalized Medicine
PROVO, Utah, March 28, 2014 /PRNewswire-iReach/ -- Tute Genomics has been selected as the next-generation sequencing (NGS) analytics pipeline for Utah-based Affiliated Genetics, Inc (AGI). AGI performs a wide variety of diagnostic services, including pharmacogenetic testing, and CLIA-certified sequencing of gene panels and whole exomes for clinicians and researchers. The Tute Genomics platform allows AGI to rapidly interpret next-generation sequencing data, including automated and customizable clinical reporting.
"Partnering with Tute Genomics has enabled us to automate our genome analytics pipeline, making the time from sequencing to interpretable results faster than ever." says Jeff Ward, President of Affiliated Genetics. The secure Tute Genomics platform annotates every genetic variant with public and proprietary data sources and scoring mechanisms. Tute also uses machine-intelligence to assign a summary score to each variant, known as the Tute score, to enable more robust variant and biomarker discovery. Tute has also recently launched a number of features including case-control and family-based analyses, custom gene panel support, and now automated clinical reporting. "A clinical report is generated for every genome and gene panel uploaded to the Tute system for manual review and approval," announced Dr. Kai Wang, President of Tute Genomics. "Ultimately, this provides a human manageable list of prioritized variants on each genome and automates the process of querying a genome for ACMG reportable incidental findings, along with indication-related findings, such as cancer somatic variants and inherited disease mutations."
According to Tute Genomics CEO, Reid Robison, MD MBA, "This pipeline that we've set up with AGI represents a big leap forward towards individualized, genomic medicine. With data streaming directly from their sequencers, we have streamlined the interpretation pipeline, allowing users to visualize and interpret human genomes with just a few clicks." Tute will be demonstrating clinical reporting and advanced analytics features at the ACMG 2014 Annual Meeting in Nashville, TN on March 27 to 28, 2014 at Booth 532. Please see www.acmgmeeting.net for more details.
About Affiliated Genetics:
Founded in 1994, Affiliated Genetics, Inc. is a privately held corporation providing dozens of medical DNA testing applications, a full range of genomic services, and DNA-based, human identity testing. Located in Salt Lake City, UT, Affiliated Genetics provides DNA testing for numerous federal, state, and local agencies, universities, commercial laboratories, and private clients. Accredited by CAP, CLIA, and AABB, Affiliated Genetics is frequently the molecular genetics laboratory performing tests for other branded services. Our laboratory provides state-of-the-art testing and outstanding customer service through a highly trained staff of scientists, technicians and customer service representatives.
About Tute Genomics:
Tute Genomics is a cloud-based clinical genome interpretation platform that enables researchers and clinicians to utilize human genetic data for scientific discovery and individualized treatment. Tute is built on the expertise that developed ANNOVAR, the most widely used genome annotation & interpretation technology with over 600 scientific publications. Tute provides robust & scalable genome analysis that incorporates proprietary machine-learning algorithms to assist researchers and clinicians with gene and biomarker discovery. To learn more please visit www.tutegenomics.com.
Media Contact: Mary Brown, Tute Genomics, (858) 779-4363, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Tute Genomics